Skip to main content

Month: January 2021

Sandy Spring Bancorp Increases Quarterly Dividend

OLNEY, Md., Jan. 28, 2021 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc., (Nasdaq- SASR), the parent company of Sandy Spring Bank, announced that the board of directors declared a quarterly common stock dividend of $0.32 per share payable on February 24, 2021 to shareholders of record on February 17, 2021. This dividend is an increase of $0.02 over the previous linked quarter and the first quarter of 2020.About Sandy Spring Bancorp, Inc./Sandy Spring BankSandy Spring Bancorp, Inc., headquartered in Olney, Maryland, is the holding company for Sandy Spring Bank, a premier community bank in the Greater Washington, D.C. region. With over 60 locations, the bank offers a broad range of commercial and retail banking, mortgage, private banking, and trust services throughout Maryland, Northern Virginia, and Washington, D.C. Through its subsidiaries,...

Continue reading

ConnectOne Bancorp, Inc. Reports Fourth Quarter and Full-Year 2020 Results

ENGLEWOOD CLIFFS, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income of $25.6 million for the fourth quarter of 2020 compared with $24.8 million for the third quarter of 2020 and $20.8 million for the fourth quarter of 2019.  Diluted earnings per share were $0.64 in the fourth quarter of 2020 compared with $0.62 in the third quarter of 2020 and $0.59 in the fourth quarter of 2019.  Full-year 2020 net income was $71.3 million, compared to $73.4 million for the full-year 2019. Diluted earnings per share for the full-year 2020 was $1.79, compared with $2.07 for the full-year 2019.Included in net income were provisions for loan losses of $5.0 million for both the fourth and third quarters of 2020 and...

Continue reading

GasLog Partners LP Declares Common Unit Distribution

Piraeus, Greece, Jan. 28, 2021 (GLOBE NEWSWIRE) — GasLog Partners LP (“GasLog Partners” or the “Partnership”) (NYSE: GLOP) today announced a cash distribution of $0.01 per common unit for the fourth quarter of 2020, payable on February 11, 2021 for all shareholders of record as of February 8, 2021.Contacts: Joseph Nelson Head of Investor Relations Phone: +1 212-223-0643 Email: ir@gaslogmlp.com About GasLog Partners GasLog Partners is a growth-oriented master limited partnership focused on owning, operating and acquiring LNG carriers under multi-year charters. GasLog Partners’ fleet consists of 15 LNG carriers with an average carrying capacity of approximately 158,000 cbm. GasLog Partners’ principal executive offices are located at 69 Akti Miaouli, 18537 Piraeus, Greece. Visit GasLog Partners’ website at http://www.gaslogmlp.com.

Continue reading

Funds Managed by Affiliates of Apollo Global Management to Acquire Showa Denko’s Aluminum Can and Aluminum Rolling Businesses

Deal Marks Apollo’s First Private Equity Investment in Japan as Firm Expands Investment Activity in the RegionTransaction Leverages Apollo’s Global Metals and Packaging Expertise and Carve-out ExperienceTOKYO and HONG KONG and NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) — Funds managed by affiliates of Apollo Global Management, Inc. (together with its consolidated subsidiaries, “Apollo” or the “Firm”) (NYSE: APO), a leading global alternative investment manager, today announced that they have entered into a definitive agreement to acquire the Aluminum Can and Aluminum Rolling Businesses (the “Business”) from Showa Denko K.K. (“Showa Denko”), a Japanese leading producer of functional chemicals and industrial materials. The deal marks the first Private Equity investment in Japan for Apollo after the Firm opened its dedicated office there...

Continue reading

Routemaster Capital Completes the Acquisition of Remaining 51% Interest in DeFi Holdings, a Company Pursuing Opportunities in the Decentralized Finance Market

TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Routemaster Capital Inc. (the “Company” or “Routemaster”) (NEO: DEFI GR: RMJR) is pleased to announce that it has closed the transaction to acquire 51% of DeFi Holdings Inc. (“DeFi Holdings”), first announced on January 14, 2021 (the “Transaction”). Please see the Company`s press release dated October 6, 2020, November 18, 2020 and January 14, 2021 for additional information on DeFi Holdings.Pursuant to the Transaction, Routemaster issued a total of 20,000,000 common shares of the Company to the shareholders of DeFi Holding in proportion to their pro rata shareholdings of DeFi Holding, in exchange for a 51% interest in DeFi Holdings. No finder fees were paid connection with, and no change of control of Routemaster resulted from, the Transaction.DeFi Holdings is a company focused on investing,...

Continue reading

EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD

WATERTOWN, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced that the first patient has been dosed in the Phase 1 clinical trial of EYP-1901 as a potential twice-yearly sustained delivery anti-VEGF treatment targeting wet age-related macular degeneration (wet AMD).EYP-1901 leverages the Company’s proprietary Durasert® drug delivery technology that has been used in four FDA-approved products, including EyePoint’s YUTIQ® for chronic non-infectious uveitis affecting the posterior segment of the eye. EYP-1901 uses a bioerodible Durasert formulation combined with a clinically validated anti-VEGF molecule, vorolanib. In oral formulation,...

Continue reading

Capital Senior Living Launches New Memory Care Program “Magnolia Trails”

DALLAS, Jan. 28, 2021 (GLOBE NEWSWIRE) — Capital Senior Living Corporation (the “Company”) (NYSE: CSU) announces the introduction of its new memory care program, Magnolia Trails, which was developed to meet the growing need for individualized programming for residents receiving memory care services.Magnolia Trails evolved out of one of the Company’s communities where the local leadership team observed improvements in resident emotional and physical well-being as a result of highly individualized programming. In partnership with internal experts and dementia care consultant and author Rachel Wonderlin, the Company applied these best practices to establish the key tenets of Magnolia Trails. The program is designed to engage the five senses to create calming yet stimulating spaces and tailored care plans that meet residents’ changing...

Continue reading

Lordstown Motors Releases Business Updates; Prepares Ohio Factory to Begin Building Betas Next Month

LORDSTOWN, Ohio, Jan. 28, 2021 (GLOBE NEWSWIRE) — Lordstown Motors Corp. (Nasdaq: RIDE), (“Lordstown Motors”), a leader in electric light duty trucks focused on the commercial fleet market, has announced another round of commercial, operational and strategic development updates as it remains on track to begin production of the Lordstown Endurance, which is anticipated to be the world’s first mass produced full-size all-electric pickup truck, this year.“We are hard at work in the factory preparing to begin Beta builds in the coming weeks,” remarked Steve Burns, Chief Executive Officer of Lordstown Motors. “With this step on the horizon, we remain on track to meet our September start-of-production timeline while continuing to see indicators of strong demand for an all-wheel drive, full-size electric pickup truck with 250 miles of...

Continue reading

AzurRx BioPharma Announces Completion of Enrollment in First Cohort of Phase 2b OPTION 2 Extension Study of MS1819

DELRAY BEACH, Fla., Jan. 28, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, today announced the completion of patient enrollment in the first cohort of the Phase 2b OPTION 2 extension study evaluating immediate-release capsules of MS1819 for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF).The Phase 2b OPTION 2 trial extension arm is currently dosing patients at clinical trial sites in the U.S. and Europe who have participated in the previous arms of the OPTION 2 trial. The goal of the MS1819 clinical program is to provide cystic fibrosis patients with a safe and effective therapy to control EPI, a debilitating gastrointestinal...

Continue reading

Jyske Bank initiates a new share buy-back programme

With the permission of the Danish Financial Supervisory Authority, Jyske Bank’s Supervisory Board has decided to initiate a new share buy-back programme of up to DKK 750m, running over the period from 28 January to 30 September 2021 at the latest.For 2019 and 2020, Jyske Bank generated a preliminary total profit before tax of DKK 5.2 bn and a preliminary profit after tax of DKK 4.0 bn. At the end of 2020, Jyske Bank’s preliminary capital ratio and preliminary Common Equity Tier 1 capital ratio were calculated at historically high levels of 23.3% and 18.4%, respectively, corresponding to 22.9% and 17.9%, respectively, when allowing for the effect of the new share buy-back programme, compared to 22.3% and 17.5% at the end of the third quarter of 2020.Yours faithfully,Jyske BankContact:Anders Dam, Managing Director and CEO, tel....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.